These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 12917048)

  • 1. T-wave alternans for risk stratification and prevention of sudden cardiac death.
    Pruvot EJ; Rosenbaum DS
    Curr Cardiol Rep; 2003 Sep; 5(5):350-7. PubMed ID: 12917048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of Prognostic Value of T-Wave Alternans for Implantable Cardioverter-Defibrillator Benefit in Primary Prevention.
    Pelli A; Kenttä TV; Junttila MJ; Huber C; Schlögl S; Zabel M; Malik M; Willems R; Vos MA; Harden M; Friede T; Sticherling C; Huikuri HV;
    J Am Heart Assoc; 2024 Jun; 13(11):e032465. PubMed ID: 38804218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy.
    Gold MR; Ip JH; Costantini O; Poole JE; McNulty S; Mark DB; Lee KL; Bardy GH
    Circulation; 2008 Nov; 118(20):2022-8. PubMed ID: 18955671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microvolt T-wave alternans for the risk stratification of dangerous ventricular arrhythmias in patients with previously implanted automatic cardioverter-defibrillator.
    Lewandowski M; Kossuth I; Zielonka J; Wielusiński M; Kazimierczak A; Kornacewicz Jach Z; Przybycień K; Kaliszczak R
    Kardiol Pol; 2011; 69(6):580-5. PubMed ID: 21678296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study.
    Salerno-Uriarte JA; De Ferrari GM; Klersy C; Pedretti RF; Tritto M; Sallusti L; Libero L; Pettinati G; Molon G; Curnis A; Occhetta E; Morandi F; Ferrero P; Accardi F;
    J Am Coll Cardiol; 2007 Nov; 50(19):1896-904. PubMed ID: 17980258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of microvolt T-wave alternans for predicting patients who would benefit from implantable cardioverter-defibrillator therapy.
    Haghjoo M; Arya A; Sadr-Ameli MA
    Cardiol Rev; 2006; 14(4):173-9. PubMed ID: 16788329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SCD-HeFT: Use of R-R interval statistics for long-term risk stratification for arrhythmic sudden cardiac death.
    Au-Yeung WT; Reinhall PG; Poole JE; Anderson J; Johnson G; Fletcher RD; Moore HJ; Mark DB; Lee KL; Bardy GH
    Heart Rhythm; 2015 Oct; 12(10):2058-66. PubMed ID: 26096609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk stratification for sudden cardiac death: is there a clinical role for T wave alternans?
    Cutler MJ; Rosenbaum DS
    Heart Rhythm; 2009 Aug; 6(8 Suppl):S56-61. PubMed ID: 19631909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ambulatory ECG-based T-wave alternans monitoring for risk assessment and guiding medical therapy: mechanisms and clinical applications.
    Verrier RL; Ikeda T
    Prog Cardiovasc Dis; 2013; 56(2):172-85. PubMed ID: 24215749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention.
    Costantini O; Hohnloser SH; Kirk MM; Lerman BB; Baker JH; Sethuraman B; Dettmer MM; Rosenbaum DS;
    J Am Coll Cardiol; 2009 Feb; 53(6):471-9. PubMed ID: 19195603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced detection of arrhythmia vulnerability using T wave alternans, left ventricular ejection fraction, and programmed ventricular stimulation: a prospective study in subjects with chronic ischemic heart disease.
    Rashba EJ; Osman AF; Macmurdy K; Kirk MM; Sarang SE; Peters RW; Shorofsky SR; Gold MR
    J Cardiovasc Electrophysiol; 2004 Feb; 15(2):170-6. PubMed ID: 15028046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive power of T-wave alternans and of ventricular gradient hysteresis for the occurrence of ventricular arrhythmias in primary prevention cardioverter-defibrillator patients.
    Man S; De Winter PV; Maan AC; Thijssen J; Borleffs CJ; van Meerwijk WP; Bootsma M; van Erven L; van der Wall EE; Schalij MJ; Burattini L; Burattini R; Swenne CA
    J Electrocardiol; 2011; 44(4):453-9. PubMed ID: 21704222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T wave alternans for ventricular arrhythmia risk stratification.
    Gold MR; Spencer W
    Curr Opin Cardiol; 2003 Jan; 18(1):1-5. PubMed ID: 12496495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of microvolt T-wave alternans to predict sudden cardiac death in patients with cardiomyopathy.
    Chauhan VS; Selvaraj RJ
    Curr Opin Cardiol; 2007 Jan; 22(1):25-32. PubMed ID: 17143041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microvolt T-wave alternans and other noninvasive predictors of serious arrhythmic events in patients with an implanted cardioverter-defibrillator.
    Sredniawa B; Kowalczyk J; Lenarczyk R; Kowalski O; Sędkowska A; Cebula S; Musialik-Łydka A; Kalarus Z
    Kardiol Pol; 2012; 70(5):447-55. PubMed ID: 22623232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T wave alternans for ventricular arrhythmia risk stratification.
    Osman AF; Gold MR
    Curr Opin Cardiol; 2002 Jan; 17(1):1-5. PubMed ID: 11790927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repolarization alternans: implications for the mechanism and prevention of sudden cardiac death.
    Walker ML; Rosenbaum DS
    Cardiovasc Res; 2003 Mar; 57(3):599-614. PubMed ID: 12618222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of a microvolt T-wave alternans screening strategy for implantable cardioverter-defibrillator placement in the MADIT-II-eligible population.
    Chan PS; Stein K; Chow T; Fendrick M; Bigger JT; Vijan S
    J Am Coll Cardiol; 2006 Jul; 48(1):112-21. PubMed ID: 16814657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Microvolt level T wave alternans: a new marker for noninvasive risk stratification].
    Klingenheben T; Credner S; Li YG; Bender B; Hohnloser SH
    Z Kardiol; 2000; 89 Suppl 3():57-61. PubMed ID: 10810786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of T-wave alternans, signal averaged electrocardiography and programmed ventricular stimulation for arrhythmia risk stratification.
    Gold MR; Bloomfield DM; Anderson KP; El-Sherif NE; Wilber DJ; Groh WJ; Estes NA; Kaufman ES; Greenberg ML; Rosenbaum DS
    J Am Coll Cardiol; 2000 Dec; 36(7):2247-53. PubMed ID: 11127468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.